Rogue Scholar Posts

language
Published in kumulonimbus

Probablemente sientes que estamos inundados con información sobre la evolución de la pandemia de COVID-19. Sin embargo, nada mejor que manejar los datos uno mismo y analizarlos desde distintos puntos de vista. Creo que siempre hay alguien que observará algo en los datos que se nos ha escapado a millones de observadores y creo que cualquier aporte en esta emergencia mundial es valioso.

Published in Europe PMC News Blog
Author Europe PMC Team

In July 2020, Europe PMC began indexing the full text of COVID-19 preprints. The initiative supported by Wellcome, the UK Medical Research Council, and Swiss National Science Foundation, has now made over 15,300 full text COVID-19 preprints searchable and free to read, alongside peer reviewed articles. Number of full text COVID-19 preprints in Europe PMC by month.

Published in Europe PMC News Blog
Author Europe PMC Team

[More than 4,500 Research Square preprints discoverable alongside peer-reviewed research]{face=“"Open Sans", sans-serif” style=“font-size: 11pt; font-style: italic; white-space: pre-wrap;”} [Research Square’s collection of more than 4,500 full-text COVID-19 preprints have been indexed in Europe PMC, an open-access repository of more than 1 million biomedical research works.]{face=“"Open Sans", sans-serif” style=“font-size: 11pt;

Published in Europe PMC News Blog
Author Europe PMC Team

[In this pandemic, researchers have responded by publishing results rapidly, often through preprints.]{style=“background-color: transparent; color: black; font-family: "arial"; font-style: normal; font-weight: 400; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;”} [In fact, up to half of the publications in Europe PMC on COVID-19 are preprints rather than peer-reviewed journal articles.

Published in iRights.info
Author Milena Leybold und Leonhard Dobusch

Gestern verkündeten die USA, den Schutz geistigen Eigentums für Covid-19-Impfstoffe aussetzen zu wollen. Wie sieht die Lage für offene Alternativen in der Entwicklung von Impfstoffen aus? Das analysieren Milena Leybold und Leonhard Dobusch: Nicht nur geistiges Eigentum ist wichtig – auch Fragen der Haftung und der Finanzierung sind maßgeblich.

Published in Elephant in the Lab
Author Elias Koch

Mafalda Sandrini Some days ago, a friend of mine told me that while she was grocery shopping, a 60 to 70 years old man shouted at her because she was wearing a mask. She was shocked: how could the man not understand she wanted to protect him? “I could be a weapon to him”, she told me. My friend, as far as she knows, did not have the COVID-19 disease, but she claimed she could not know for sure.

Published in Elephant in the Lab
Author Sascha Schönig

***The COVID-19 pandemic experiences of many different countries have shown how an exceptional need for research evidence has led to rapid new deployments of scientists in advisory roles to aid policymakers in making evidence-informed decisions. (1) This has helped us learn how science advisors experience, and try to manage, the challenges of insufficient, evolving, and conflicting evidence as they work to inform public health decision-making.

Published in Elephant in the Lab
Author Sascha Schönig

Introduction The outbreak of the COVID-19 pandemic led to a global and accelerated digitalisation of all education systems. This quickly revealed many inequalities in access to digital resources and lack of digital skills. What concrete impact has this had on learners and teachers worldwide? How can we address these inequalities in education?